Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells

被引:34
作者
Shan, Juan [1 ,2 ]
Feng, Li [1 ]
Sun, Guixiang [1 ]
Chen, Peng [1 ]
Zhou, Yanni [1 ]
Xia, Mengjuan [1 ]
Li, Hongsheng [1 ]
Li, Youping [1 ,3 ]
机构
[1] Sichuan Univ, West China Hosp, Hlth Minist China, Key Lab Transplant Engn & Immunol, Chengdu 610041, Sichuan Provinc, Peoples R China
[2] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu 610041, Sichuan Provinc, Peoples R China
[3] Chinese Evidence Based Med Ctr, Chinese Cochrane Ctr, Chengdu 610041, Sichuan Provinc, Peoples R China
关键词
Regulatory T cell; mTOR signaling; STAT5; signaling; MicroRNA-155; Immune balance; Rapamycin; INDUCTION; SURVIVAL; SUPPRESSION; INHIBITION; SIROLIMUS; RESPONSES;
D O I
10.1016/j.imbio.2014.10.020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Immune response outcome, inflammation or tolerance, often depends on the balance between regulatory T cells (Tregs) and effective T cells (Teffs). Rapamycin (Rapa) has been reported to selectively expand Tregs and promote de novo generation of foxp3(+) Tregs, suggesting its potential role in inducing tolerance. But the mechanism by which Rapa regulating the Treg-Teff balance is yet to be understood. Methods: Mouse CD4(+)CD25(-) Teffs and CD4(+)CD25(+) Tregs are sorted by MACS. These T cell subsets were labeled with CFSE and cultured with anti-CD3/CD28 Ab +/- IL-2 for 6 days. Two rounds of stimulation of 3 days each were performed. Rapa or Jak Inhibitor I was added to the culture when indicated. Cells were harvested after each round of stimulation. CFSE dilution, FOXP3, miR-155 expression and the signaling via the mTOR and STAT5 pathways were determined. And miR-155-mimic and miR-155-antagomir were transfected into purified CD4(+) T cells respectively to detect miR-155 role in regulating STAT5 signaling. Results: Firstly, we confirmed that the effect of Rapa on proliferating T cells is time-dependent: it reduces both Teffs and Tregs proliferation at early stage, but selectively promotes Tregs proliferation after second round of stimulation. Then we found there is direct interaction between mTOR and STAT5 signaling, and this interaction explained the time-dependent effect of Rapa and may participate in deciding Teff-Treg balance: mTOR inhibition up-regulated the expression of phos-STAT5 in both proliferating Tregs and Teffs via miR-155. And foxp3 is the down streaming target of phos-STAT5, thus Rapa could maintain expanded Tregs function and promote de novo generation of foxp3(+) Tregs. However, the phos-4E-BP1 expression pattern is different in proliferating Tregs and Teffs. 4E-BP1 is the common target of mTOR and STAT5 signaling, and plays a key role in cell proliferation. Rapa inhibits phos-4E-BP1 expression in both Tregs and Teffs at early stage of proliferation, but selectively raises its expression in Tregs after second round of stimulation. This may explains why Rapa inhibits Teffs growth, but delays Tregs proliferation. Conclusion: Together, these findings indicate that the dynamic interaction between mTOR and STAT5 signaling modulates the reciprocal differentiation of the effective and regulatory T cells, and differently affect their proliferation activity. This provides a new insight of how Treg-Teff balance is regulated. (C) 2014 Elsevier GmbH. All rights reserved.
引用
收藏
页码:510 / 517
页数:8
相关论文
共 24 条
[1]   Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance [J].
Antov, A ;
Yang, L ;
Vig, M ;
Baltimore, D ;
Van Parijs, L .
JOURNAL OF IMMUNOLOGY, 2003, 171 (07) :3435-3441
[2]   Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin [J].
Basu, Samik ;
Golovina, Tatiana ;
Mikheeva, Tatiana ;
June, Carl H. ;
Riley, James L. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (09) :5794-5798
[3]   Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells [J].
Battaglia, M ;
Stabilini, A ;
Roncarolo, MG .
BLOOD, 2005, 105 (12) :4743-4748
[4]   Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells [J].
Bensinger, SJ ;
Walsh, PT ;
Zhang, JD ;
Carroll, M ;
Parsons, R ;
Rathmell, JC ;
Thompson, CB ;
Burchill, MA ;
Farrar, MA ;
Turka, LA .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5287-5296
[5]   Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation [J].
Bestard, Oriol ;
Cassis, Linda ;
Cruzado, Josep M. ;
Torras, Joan ;
Franquesa, Marcella ;
Gil-Vernet, Salvador ;
Lucia, Marc ;
Grinyo, Josep M. .
TRANSPLANT INTERNATIONAL, 2011, 24 (05) :451-460
[6]   Successful resolution of inflammation and increased regulatory T cells in sirolimus-treated post-transplant allograft hepatitis [J].
Ekong, Udeme D. ;
Mathew, James ;
Melin-Aldana, Hector ;
Wang, Deli ;
Alonso, Estella M. .
PEDIATRIC TRANSPLANTATION, 2012, 16 (02) :165-175
[7]   Integrated T-cell receptor and costimulatory signals determine TGF-β-dependent differentiation and maintenance of Foxp3+ regulatory T cells [J].
Gabrysova, Leona ;
Christensen, Jillian R. ;
Wu, Xuemei ;
Kissenpfennig, Adrien ;
Malissen, Bernard ;
O'Garra, Anne .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (05) :1242-1248
[8]   CD28 costimulation is essential for human T regulatory expansion and function [J].
Golovina, Tatiana N. ;
Mikheeva, Tatiana ;
Suhoski, Megan M. ;
Aqui, Nicole A. ;
Tai, Victoria C. ;
Shan, Xiaochuan ;
Liu, Ronghua ;
Balcarcel, R. Robert ;
Fisher, Nancy ;
Levine, Bruce L. ;
Carroll, Richard G. ;
Warner, Noel ;
Blazar, Bruce R. ;
June, Carl H. ;
Riley, James L. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (04) :2855-2868
[9]   Generation of Donor-Specific Regulatory T-Cell Function in Kidney Transplant Patients [J].
Hendrikx, Thijs K. ;
van Gurp, Evelien A. F. J. ;
Sewgobind, Varsha D. K. D. ;
Mol, Wendy M. ;
Schoordijk, Wenda ;
Klepper, Masriska ;
Velthuis, Jurjen H. L. ;
Geel, Annemarie ;
Ijzermans, Jan N. M. ;
Weimar, Willem ;
Baan, Carla C. .
TRANSPLANTATION, 2009, 87 (03) :376-383
[10]   MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene [J].
Jiang, Shuai ;
Zhang, Hong-Wei ;
Lu, Ming-Hua ;
He, Xiao-Hong ;
Li, Yong ;
Gu, Hua ;
Liu, Mo-Fang ;
Wang, En-Duo .
CANCER RESEARCH, 2010, 70 (08) :3119-3127